Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PerkinElmer Revenues Grow 4%

Published: Monday, February 03, 2014
Last Updated: Monday, February 03, 2014
Bookmark and Share
PerkinElmer, Inc. reported financial results for the fourth quarter ended December 29, 2013.

The Company reported GAAP earnings per share from continuing operations of $0.58, compared to a loss of $0.14 in the fourth quarter of 2012. Revenue in the fourth quarter of 2013 was $593.3 million, as compared to $572.9 million in the fourth quarter of 2012. GAAP operating income from continuing operations for the fourth quarter of 2013 was$84.7 million, as compared to an operating loss of $30.8 million in the fourth quarter of 2012, impacted by non-cash charges and other adjustments noted in the Company's reconciliations of non-GAAP financial measures.

Adjusted earnings per share was $0.73, compared to $0.65 in the fourth quarter of 2012. Adjusted revenue for the quarter grew 3% to $594.0 million, compared to $577.0 million in the fourth quarter of 2012. Adjusted operating income for the fourth quarter of 2013 was $114.1 million, compared to $105.6 million for the same period a year ago. Adjusted operating profit margin was 19.2% as a percentage of adjusted revenue, compared to 18.3% for the same period a year ago. Adjustments for the Company's non-GAAP financial measures have been noted in the attached reconciliations.

"We are pleased with our strong finish to the year as we delivered solid performances in adjusted earnings per share growth, adjusted operating margin expansion and operating cash flow generation, " said Robert Friel, chairman and chief executive officer of PerkinElmer. "By leveraging our recent growth and productivity investments, we are well positioned to deliver a year of profitable revenue growth while continuing to address the critical health and environmental needs of our customers throughout the world."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PerkinElmer Sells NTD to Eurofins
PerkinElmer has announced that it sold its U. S. prenatal screening laboratory services business PerkinElmer Labs/NTD ("NTD") to Eurofins Scientific.
Tuesday, April 26, 2016
PerkinElmer Signals™ Perspectives Launches in Collaboration with Attivio
New data discovery solution leverages Attivio's platform to provide insight into complex scientific challenges.
Tuesday, February 02, 2016
PerkinElmer Collaborates with Waters on Chromatography Solutions
PerkinElmer, Inc. has announced a chromatography collaboration with Waters Corporation to deliver market leading software and premium instruments to PerkinElmer’s customers.
Wednesday, February 18, 2015
PerkinElmer, Sofie Biosciences Announce Benchtop PET Imaging Partnership
Preclinical PET imaging instruments in benchtop format help support high performance disease research, drug discovery and clinical translational applications.
Tuesday, June 10, 2014
Good Start Genetics, PerkinElmer Collaboration Expands Access to Genetic Carrier Screening Tests
Strategic agreement will broaden access to GoodStart Select™ tests to include obstetrics and gynecology and maternal fetal medicine physicians.
Monday, March 17, 2014
CAS and PerkinElmer Combine the Power of SciFinder and ChemBioDraw
New functionality will enable ChemBioDraw users to search in SciFinder, providing access to comprehensive content available in the CAS databases.
Tuesday, December 17, 2013
PerkinElmer Announces Strategic Alliance with Integromics
PerkinElmer becomes the sole worldwide distributor of Integromics’ software for the TIBCO Spotfire.
Tuesday, June 25, 2013
PerkinElmer to Host Revolutionaries for Global Health Summit
Company to assemble thought leaders to share pioneering personalized health research and innovations.
Wednesday, May 01, 2013
ViaCord® Collaborates with the Center for International Blood and Marrow Transplant Research®
PerkinElmer’s family cord blood banking business and international research organization collaborates to analyze quality and outcomes of cord blood stem cell units.
Wednesday, May 01, 2013
PerkinElmer and MGH Pathology Collaborate
Collaboration to develop a complete sequencing informatics system for cancer research.
Wednesday, September 12, 2012
PerkinElmer and TPM Biotech SDN. BHD. Partner to Validate Screening Application for Halal Food Products
Companies collaborate to explore potential applications of PerkinElmer’s Porcine Detection Kits and chromatography solutions for use in validating methods of testing food products for compliance with Halal certification regulations.
Tuesday, April 10, 2012
PerkinElmer Announces Collaboration with Rutgers University Cell and DNA Repository
Companies team up to enable large-scale sequencing studies through more efficient automation and improving next generation sequencing sample access.
Tuesday, February 21, 2012
PerkinElmer Announces Collaboration with Rutgers University Cell and DNA Repository
Rutgers University Cell and DNA Repository has adopted PerkinElmer’s technologies for automation of Next Generation Sequencing sample preparation.
Thursday, February 16, 2012
PerkinElmer Expands Reagent Portfolio for Faster Identification of Epigenetic Drug Candidates
The company announced the launch of four new cellular assay kits to help identify and characterize possible drug candidates targeting epigenetic enzymes related to key disease states.
Tuesday, February 07, 2012
PerkinElmer to Acquire Caliper Life Sciences
PerkinElmer, Inc. announces that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc. for a total net purchase price of approximately $600 million.
Wednesday, September 21, 2011
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!